Lannett Co Inc (LCI): Mahendra Dedhiya , Chief Scientific Affairs of Lannett Co Inc purchased 1,000 shares on Feb 5, 2016. The Insider buying transaction was reported by the company on Jul 6, 2016 to the Securities and Exchange Commission. The shares were purchased at $24.84 per share for a total value of $24,840.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 24, 2016, Robert Ehlinger (VP and CIO) sold 37,141 shares at $25.07 per share price.On Feb 8, 2016, Albert Iii Paonessa (director) purchased 2,500 shares at $24.57 per share price.Also, On Feb 8, 2016, Martin P Galvan (CFO) purchased 3,000 shares at $24.65 per share price.On Feb 8, 2016, Paul Taveira (director) purchased 1,000 shares at $23.60 per share price.
Shares of Lannett Company (LCI) ended Tuesday, Jul 6, 2016 session in red amid volatile trading. The shares closed down -0.27 points or -1.08% at $24.67 with 4,20,596 shares getting traded. Post opening the session at $24.94, the shares hit an intraday low of $24.245 and an intraday high of $24.96 and the price vacillated in this range throughout the day. The company has a market cap of $907 M and the number of outstanding shares has been calculated to be 3,67,47,501 shares. The 52-week high of Lannett Company is $62.9 and the 52-week low is $16.91.
Company has been under the radar of several Street Analysts.Lannett Company is Initiated by Deutsche Bank to Hold and the brokerage firm has set the Price Target at $26. The Rating was issued on Jun 29, 2016.
Lannett Company Inc. develops manufactures markets and distributes generic versions of brand pharmaceutical products. The Company’s products include Levothyroxine Sodium tablets Digoxin tablets Butalbital products Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products such as Cocaine Topical Solution (C-Topical) Morphine Sulfate Oral Solution Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.